GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
0 hedge funds and large institutions have $0 invested in GeneDx Holdings Warrant in 2026 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
100% less funds holding
Funds holding: 14 → 0 (-14)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $11.5K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LMR Partners
London,
United Kingdom
|
-$8.54K |
| 2 |
D.E. Shaw & Co
New York
|
-$1.36K |
| 3 |
StoneX Group
New York
|
-$703 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$420 |
| 5 |
Wolverine Asset Management
Chicago,
Illinois
|
-$241 |
WGSWW Hedge Fund Activity: Q3 2026 in Review
0 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q3 2026, worth a combined $0 — down 100% from $11.5K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of WGSWW and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $8.54K sold.
- 0 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q3 2026, down from 14 in Q2 2026.
- Funds reported $0 of GeneDx Holdings Warrant stock for Q3 2026, down 100% quarter-over-quarter.
- 0 funds opened new GeneDx Holdings Warrant positions in Q3 2026 and 14 closed out, a net change of -14 holders.
- The largest GeneDx Holdings Warrant seller in Q3 2026 was LMR Partners, an estimated $8.54K sold.
Based on aggregated 13F filings for Q3 2026.